Is ARS Pharmaceuticals, Inc. (SPRY) a Buy, Sell, or Hold?
ARS Pharmaceuticals, Inc.
NASDAQ:SPRY
$7.61 USD
-$0.13 (-1.68%)
- Volume
- 1.91M
- Average Volume
- 1.8M
- Market Capitalization
- $755.7M
- P/E Ratio
- -3.79
- Dividend Yield
- 0.00%
- Price Target
- $25.50
- Year High
- $18.63
- Year Low
- $6.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.94
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-70.2% DOWNSIDE
$25.50 Price Target
UPSIDE/DOWNSIDE HIGH
-70.7% DOWNSIDE
$26.00 Price Target High
UPSIDE/DOWNSIDE LOW
-69.6% DOWNSIDE
$25.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Leerink Partners | Roanna Ruiz | $26 | $9.28 | 2026-03-10 06:22 AM | 180.2% |
| Roth Capital | Kyle Bauser | $30 | $8.415 | 2025-11-04 07:53 AM | 256.5% |
| Cantor Fitzgerald | Josh Schimmer | $30 | $14.24 | 2024-08-19 01:06 PM | 110.7% |
| Raymond James | Strong Buy | $22 | $10.85 | 2024-08-12 12:28 PM | 102.8% |
| Raymond James | Ryan Deschner | $18 | $10.4 | 2024-07-25 02:30 AM | 73.1% |
| Leerink Partners | Roanna Ruiz | $18 | $8.65 | 2024-03-05 01:07 AM | 108.1% |